Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Study ID: NCT07238556
Start Date: 2026-01-01
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

12 Week P3-EX Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants

12 Week ACSM-PAVS Unsupervised Exercise Program with Virtual Weekly Oversight from Graduate Research Assistants

Sponsor

University of Connecticut

Source: clinicaltrials.gov

Share:
Add to list

Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma

Study ID: NCT07269639
Start Date: 2026-01-01
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Golcadomide + Poseltinib + Rituximab

Sponsor

Seoul National University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

Study ID: NCT06187701
Start Date: 2026-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Co-Active Therapeutic Theatre (Co-ATT)

Sponsor

Boston Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Couples' Affect in Relationships Study

Study ID: NCT06907654
Start Date: 2026-03
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

well-being app

List of well-being resources

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Study ID: NCT07266831
Start Date: 2026-01-14
End Date: 2030-04-25
Study Type

Interventional

Study Phase

Phase3

No. of Participants

570

Intervention / Treatment

ISL

HEAD

BIC/FTC/TAF

Placebo for BIC/FTC/TAF

Placebo to ISL/ULO

ISL/HEAD

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

TCDS for the Treatment of Chronic Migraine

Study ID: NCT07214454
Start Date: 2026-02-01
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Transcranial direct current stimulation (Nettle device) 2mA stimulation for 20 minutes per day

Sponsor

University College, London

Source: clinicaltrials.gov

Share:
Add to list

Video Intervention to Reduce Depression-related Stigma Among Adolescents

Study ID: NCT07282366
Start Date: 2025-12-20
End Date: 2026-12-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Video-Based Psychoeducation on Personal Stigma

Video-Based Psychoeducation on Social Stigma (Non-Depressed Adolescents)

Neutral Health Education Video

Sponsor

Jian-Jun Ou

Source: clinicaltrials.gov

Share:
Add to list

Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus

Study ID: NCT07187856
Start Date: 2026-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

PG-102

Placebo

Semaglutide

Sponsor

ProGen. Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

Study ID: NCT06881927
Start Date: 2026-02-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

212

Intervention / Treatment

Hydrocortisone Hemisuccinate: 200 mg per day.

reduction of the level of immunosuppression

Sponsor

University Hospital, Strasbourg, France

Source: clinicaltrials.gov

Share:
Add to list

Modeling Host-Pathogen Interaction Using Lymphoid Organoids

Study ID: NCT06479837
Start Date: 2025-12-18
End Date: 2044-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list